CorMedix Inc. CRMD Income Statement

Cormedix inc. (CRMD)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue
Net sales
193	283	285	597	570	429	495	184	312	329	358	341	222	224	125	116	220	210	272	288	208	189	106	53	14	2	0	0	0	-	-	-	-	-	-	-	-	-	-
Cost of sales
194	373	349	582	595	396	311	65	49	114	263	240	410	366	117	37	-251	-318	-428	-429	-382	-445	-373	-337	-282	-201	0	0	0	-	-	-	-	-	-	-	-	-	-
Gross profit (loss)
-1	-89	-64	15	-24	33	184	118	263	214	94	101	-187	-142	-320	-320	-131	-108	-156	-140	-173	-256	-267	-283	-268	-199	0	0	0	-	-	-	-	-	-	-	-	-	-
Operating Expenses
Research and development
10,650	11,052	4,028	9,796	13,417	18,822	31,627	29,352	27,842	24,486	20,060	20,886	18,569	15,735	13,188	8,112	7,136	6,281	5,297	3,825	2,200	1,318	658	1,116	1,324	1,226	1,683	1,177	1,034	1,142	420	1,900	3,246	4,058	5,243	4,079	0	0	0
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,857	2,198	2,329	2,850	3,148	3,251	2,992	0	0	0
Selling, general and administrative
11,045	9,865	9,400	8,782	8,156	8,074	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Total operating expenses
21,695	20,917	13,429	18,579	21,573	26,897	39,457	37,162	35,756	33,138	29,290	30,442	28,043	24,618	21,791	17,346	16,757	16,545	14,819	11,985	9,707	8,645	7,984	7,360	6,774	4,715	3,846	3,581	2,906	2,999	2,619	4,230	6,096	7,206	8,494	7,071	0	0	0
Loss From Operations
-21,696	-21,007	-13,493	-18,563	-21,598	-26,864	-39,272	-37,043	-35,493	-32,924	-29,195	-30,341	-28,231	-24,760	-22,111	-17,666	-16,888	-16,653	-14,975	-12,126	-9,881	-8,902	-8,252	-7,643	-7,043	-4,915	-3,846	-3,581	-2,906	-2,999	-2,619	-4,230	-6,096	-7,206	-8,494	-7,071	0	0	0
Other Income (Expense)
Interest income
327	322	253	166	80	36	51	83	102	110	122	117	118	126	119	112	91	60	34	10	2	2	2	1	1	0	0	0	1	1	3	5	7	12	20	24	0	0	0
Foreign exchange transaction loss
-22	-21	-19	-6	7	-0	-6	-11	-21	-13	-14	-10	-8	-8	-6	-5	-6	-6	0	0	0	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Loss on issuance of preferred stock, convertible notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-
Value of warrants issued in connection with backstop financing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,583	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign exchange transaction gain (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-155	-31	-12	-4	0	-0	0	0	0	0	0	-	-	-	-	-	-
Loss on issuance of preferred stock, convertible notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-8,848	-9,258	-8,626	-14,045	-363	45	0	0	-	0	-	-	-	-	-	-	-	-
Loss on modification of equity instruments and extinguishment of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-
Loss on modification of equity instruments and extinguishment of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
491	787	781	608	302	1	4	7	7	5	3	0	0	1	-1	0	4	3	6	5	2	2	31	343	1,004	1,444	1,770	1,484	823	382	26	0	0	-	0	-	-	-	0
Total other income (expense)
-	-	-547	-448	-	34	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss Before Income Taxes
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other income (expense)
0	-	-	-	0	-	-	-	-	-85	0	0	0	-	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
LOSS BEFORE INCOME TAXES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,728	-3,380	-2,642	-4,224	-6,089	-7,165	-8,444	-7,017	0	0	0
Tax benefit
-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	-	0	-	-	-	0
Net Loss
-16,822	-16,433	-8,980	-13,951	-21,812	-26,829	-39,288	-39,008	-35,598	-33,009	-29,211	-28,381	-28,122	-24,643	-21,997	-17,559	-16,808	-18,187	-16,535	-16,882	-9,237	-20,453	-21,674	-19,139	-24,599	-9,133	-6,549	-5,066	-3,728	-3,380	-2,148	-3,730	-5,595	-6,671	-8,444	-7,017	0	0	0
Other Comprehensive Loss
Unrealized loss from investment
-4	0	0	7	0	-	-	2	2	13	6	-2	21	11	-7	5	-25	-24	0	-5	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign currency translation loss
-0	0	6	-0	-0	-1	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Total other comprehensive loss
-4	0	11	6	-1	-1	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive Loss
-16,827	-16,432	-8,969	-13,944	-21,814	-26,831	-39,292	-39,008	-35,591	-32,992	-29,200	-28,374	-28,124	-24,624	-22,014	-17,562	-16,817	-18,224	-16,552	-16,788	-9,125	-20,345	-21,557	-19,140	-24,610	-9,142	0	0	0	-	-	-	-	-	-	-	-	-	-
Net Loss
-16,822	-16,433	-8,980	-13,951	-21,812	-26,829	-39,288	-39,008	-35,598	-33,009	-29,211	-28,381	-28,122	-24,643	-21,997	-17,559	-16,808	-18,187	-16,535	-16,882	-9,237	-20,453	-21,674	-19,139	-24,599	-9,133	-6,549	-5,066	-3,728	-3,380	-2,148	-3,730	-5,595	-6,671	-8,444	-7,017	0	0	0
Deemed dividend as a result of warrant modification
-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend as a result of exchange of convertible note and Series C-2, Series D and Series F preferred stock, related party
-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Loss Attributable to Common Shareholders
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends, including deemed dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	0	-	0	-	-	-	-	-	-
Deemed dividend - beneficial conversion feature
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-
Net Loss Attributable To Common Shareholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-
Net Loss Per Common Share – Basic and Diluted (in Dollars per share)
-0.21	-0.20	-1.35	-0.03	-0.22	0.23	-0.54	-0.52	-0.68	-0.14	-0.17	-0.10	-0.19	-0.18	-0.23	-0.13	-0.11	-0.08	-0.14	-0.13	-0.23	-	-0.23	-	-0.87	-	-0.18	-	-0.13	-0.08	-0.09	-0.05	-0.08	0.04	-0.23	-0.22	-0.17	-0.12	-0.10
Weighted Average Common Shares Outstanding – Basic and Diluted (in Shares)
26,059	25,692	24,015	23,825	23,074	20,893	18,831	16,470	15,071	67,065	60,290	52,583	40,624	40,355	39,053	36,447	36,012	35,243	34,585	31,623	23,921	-	22,080	-	19,264	-	14,430	-	11,603	11,408	11,408	11,408	11,408	-	11,408	11,408	-	-	-
Net Loss Per Common Share - Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.12	-	-	-	-0.15	-	-	-	-	-	-	-	-	-	-	-
Weighted Average Common Shares Outstanding - Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21,993	-	-	-	13,048	-	-	-	-	-	-	-	-	-	-	-
Net Loss Per Common Share - Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.05	-	-	-	-0.15	-	-	-	-	-	-	-	-	-	-	-
Weighted Average Common Shares Outstanding - Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25,439	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted Average Common Shares Outstanding - Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,048	-	-	-	-	-	-	-	-	-	-	-
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,408	11,408	11,408